Evidence suggests superbugs could cost the global economy up to 3.5% of GDP – and push 28 million more people into poverty. Drastic solutions and innovation is needed.
Decades of antibiotic overuse in healthcare and farming have led to a rapid rise in antibiotic resistance worldwide. Dr Natalie Whitfield, Director of Scientific and Medical Affairs at GenMark Diagnostics explains how new, rapid diagnostic technology can help fight this potential health crisis.
Drug-resistant organisms are evolving extremely quickly. So we are now faced with a challenge, in that people in hospitals and the community develop resistant infections and we don’t have effective drugs to treat them.
Neglected Tropical Diseases (NTDs) affect over one billion of the world’s poorest people. We look at how international collaboration and partnerships are starting to turn the tide of misery.
Sir Ronald Cohen is Chair of the Global Steering Group for Impact Investing (GSG), described as "the father of British venture capital" and "the father of social investment", with 18 years devoted to pioneering the impact investing movement.